BEAM (BEAM) is trading at $0.001461 down 0.63% over the past 24 hours. Its Galaxy Score is 62.9, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 15.7K engagements and 112 posts with 88% positive social sentiment.
AI summary: BEAM is a biotech-themed cryptocurrency token associated with gene-editing equities like Beam Therapeutics, trading as a Layer 1 asset on Ethereum, BNB Chain, and Base. The 14.55% weekly gain was fueled by Moderna's Phase 3 cancer vaccine win triggering speculative inflows and a 158% volume surge, but the -4.83% 24-hour dip near $0.00153 reflects profit-taking at range resistance as licensing caps and macro volatility prevent social hype from converting into sustained appreciation.